Wire Stories
ClearB Therapeutics Announces Acceptance of Abstract Highlighting New Pre-Clinical Hepatitis B Data as a Poster Presentation at EASL 2021
CONCORD, Mass. & MELBOURNE, Australia–(BUSINESS WIRE)–ClearB Therapeutics, Inc., a company developing a therapeutic vaccine designed to drive functional cure of hepatitis B,...